TrialDiabetologia2018

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.

Jan W Eriksson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.